Drug Development Solutions
-
Nitrosamine Capabilities
8/22/2024
Pinpoint impurities and conduct confirmatory testing under cGMP with the help of an expert team utilizing cutting-edge mass spectrometry technology to boost your drug product development.
-
Integrated Biotech Services: From Strain To Commercial Product
Backed by Lonza’s more than 30 years’ experience and expertise in biological processing and our track record in the chemical and biotechnological industry, we offer our customers a full “one-stop-shop” service package at all stages of development and production.
-
Microbiology Testing: Health Inspired, Quality Driven
4/22/2024
Whether driven by regulatory mandates or the need to maintain sterility, our services can assist you in meeting these requirements efficiently and accurately, thereby safeguarding patient well-being.
-
ATP Detection By Quantitative Mass Spec Imaging (QMSI)
2/5/2025
By leveraging this approach, researchers can streamline workflows, reduce costs, and enhance the efficiency of their bioanalytical processes.
-
Drug Development And CMC Testing Solutions
4/12/2024
Learn how a partner with comprehensive services can help you reduce development risks, shorten time to market, and navigate complex global regulations with ease.
-
Advancing Vaccines From Preclinical Development To Commercial Supply
We are an established leader in advancing vaccines from preclinical development to commercial supply across multiple modalities.
-
European Center Of Excellence For Clinical Biologics
Explore how our proven expertise and simplified execution with development, filling, and analytical under one roof ensure safe, efficacious products reach patients in need.
-
Peptide Development Strategies
10/27/2022
Peptides occupy a therapeutic niche between small molecules and large biologics. We understand the fundamental physiological challenges to peptide delivery and that there is no “one-size-fits-all” approach for formulation design.
-
Development And Manufacturing Services
4/29/2021
Adare Pharma Solutions is a leading specialty contract development and manufacturing organization (CDMO) and a leading global provider of advanced pharmaceutical technologies, formulation, development, and manufacturing.
-
GENE TO GMP*: First-In-Human In 8 Months With Optimized Cost
3/27/2025
We drive innovation and excellence in biologics, offering integrated solutions that help clients efficiently advance their research and successfully bring their products to market.